High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells.

We have developed an improved method for preparing cell aggregates for in vitro chondrogenesis studies. This method is a modification of a previously developed conical tube-based culture system that replaces the original 15-mL polypropylene tubes with 96-well plates. These modifications allow a high-throughput approach to chondrogenic cultures, which reduces both the cost and time to produce chondrogenic aggregates, with no detrimental effects on the histological and histochemical qualities of the aggregates. We prepared aggregates in both systems with human bone marrow-derived mesenchymal stem cells (hMSC). The aggregates were harvested after 2 and 3 weeks in chondrogenic culture and analyzed for their ability to differentiate along the chondrogenic pathway in a defined in vitro environment. Chondrogenic differentiation was assessed biochemically by DNA and glycosaminoglycan (GAG) quantification assays and by histological and immunohistologic assessment. The chondrogenic cultures produced in the 96-well plates appear to be slightly larger in size and contain more DNA and GAG than the aggregates made in tubes. When analyzed histologically, both systems demonstrate morphological characteristics that are consistent with chondrogenic differentiation and cartilaginous extracellular matrix production.

[1]  V. Goldberg,et al.  BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. , 2001, Journal of cellular biochemistry.

[2]  Scott P. Bruder,et al.  Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation , 1996, In Vitro Cellular & Developmental Biology - Animal.

[3]  V. Goldberg,et al.  FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells , 2005, Journal of cellular physiology.

[4]  J. Welter,et al.  Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. , 2004, Methods in molecular medicine.

[5]  F. Barry,et al.  Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. , 2000, Journal of biomedical materials research.

[6]  A I Caplan,et al.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.

[7]  M. Iwamoto,et al.  Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Reddi,et al.  Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium , 1994, The Journal of cell biology.

[9]  A I Caplan,et al.  Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.

[10]  J. Arias,et al.  A spectrophotometric modification of a sensitive densitometric Safranin O assay for glycosaminoglycans. , 1991, Biochemistry international.

[11]  V. Goldberg,et al.  BMP‐2 induction and TGF‐β1 modulation of rat periosteal cell chondrogenesis , 2001 .

[12]  J. Abbott,et al.  THE LOSS OF PHENOTYPIC TRAITS BY DIFFERENTIATED CELLS IN VITRO, I. DEDIFFERENTIATION OF CARTILAGE CELLS. , 1960, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Goldberg,et al.  The Chondrogenic Potential of Human Bone-Marrow-Derived Mesenchymal Progenitor Cells* , 1998, The Journal of bone and joint surgery. American volume.

[14]  M. Sporn,et al.  TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. , 1993, Developmental biology.